No Data
No Data
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen's 4th Annual Novel Mechanisms in Neuropsychiatry Summit
TD Cowen Sticks to Their Buy Rating for Rapport Therapeutics, Inc. (RAPP)
Rapport Therapeutics GAAP EPS of -$1.70 Misses by $1.02
Express News | Rapport Therapeutics Ended The Quarter With $336.1M In Cash, Cash Equivalents, And Short-term Investments, Excluding Restricted Cash, Which Is Expected To Fund Operations Through The End Of 2026
Express News | Rapport Therapeutics Q2 2024 GAAP EPS $(1.70) Misses $(0.68) Estimate
No Data